<DOC>
	<DOCNO>NCT01770964</DOCNO>
	<brief_summary>The difference active treatment placebo clinical trial analgesic appear depend variety factor actual efficacy drug , include various aspect study design conduct . One potential factor information study present research staff patient . The purpose study examine impact different presentation information difference pregabalin placebo observe clinical trial patient painful diabetic neuropathy .</brief_summary>
	<brief_title>Evaluation Impact Training Outcome Measures Subjects With Painful Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Willingly sign date Informed Consent Form ( ICF ) approve Institutional Review Board/Independent Ethics Committee ( IRB/IEC ) , prior conduct studyspecific procedure ; Is least 18 year old ; Has diagnosis type 1 type 2 diabetes painful distal symmetric sensorimotor polyneuropathy ; Has experience minimum duration PDN least 6 month ; Is stable diabetic medication expect change study ; Has bad pain intensity past 24 hour 4 high 010 numerical rating scale Screening ; And able read communicate meaningfully English comply study procedure Has psychiatric psychological disorder judgment Investigator would interfere completion study , confound study result , pose subject risk ; Has uncontrolled , clinically significant medical condition judgment Investigator may contraindicate use pregabalin participation study ( e.g. , hepatic , respiratory , hematologic illness ; cardiovascular disease ; symptomatic peripheral vascular disease ) ; Has experience investigator study staff member clinical trial research role involve direct patient contact ; Participated follow study : Analgesic Solutions Protocol # ALPMF.SOW.0007 , Analgesic Solutions Protocol # ALPMF.SOW.0007.02 , Astellas Protocol # E05CL3004 ; Has pain origin might confound assessment PDN ; Has major skin ulceration ; Has amputation toe ; Has history suicide attempt within past 1 year ; Reports current suicidal ideation within past 1month ; Has history kidney disease likely decrease creatinine clearance ; Has creatinine clearance 60 calculate CockroftGault equation serum creatinine ; Has history drug alcohol abuse within past 1 year ; Has hypersensitivity , intolerance , allergy pregabalin gabapentin ; Subject pregnant , consider become pregnant study , breastfeed unwilling use adequate birth control study ; Participated another clinical trial within past month ; Is involve ongoing settle worker 's compensation claim , disability , litigation ; Has know failure respond pregabalin gabapentin clinically relevant dose due either efficacy tolerability ; Or take opioids asneeded basis within 1week Screening , take pregabalin gabapentin within 30 day screen . Subjects stable dos opioids , antidepressant , nonsteroidal antiinflammatory drug , lowdose aspirin allow participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>